Pee and Period Proof Underwear and Nursing Pads Revenue and Competitors

Location

N/A

Total Funding

Apparel

Industry

Estimated Revenue & Valuation

  • Pee and Period Proof Underwear and Nursing Pads's estimated annual revenue is currently $3.2M per year.(i)
  • Pee and Period Proof Underwear and Nursing Pads's estimated revenue per employee is $159,600

Employee Data

  • Pee and Period Proof Underwear and Nursing Pads has 20 Employees.(i)
  • Pee and Period Proof Underwear and Nursing Pads grew their employee count by 18% last year.

Pee and Period Proof Underwear and Nursing Pads's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
Founder and Design DirectorReveal Email/Phone
3
VP I Sales & Marketing HeadReveal Email/Phone
4
Operations ManagerReveal Email/Phone
5
Digital / e-commerce ManagerReveal Email/Phone
6
Product Development ManagerReveal Email/Phone
7
Project ManagerReveal Email/Phone
8
Marketing ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$106.6M37436%N/AN/A
#2
$12.7M640%$16.7MN/A
#3
$13M0N/A$13.5MN/A
#4
$25.8M1136%N/AN/A
#5
$245.8M77011%N/AN/A
#6
$13.5M666%N/AN/A
#7
$7.1M3911%N/AN/A
#8
$248M7778%N/AN/A
#9
$38.1M15222%N/AN/A
#10
$24.4M1073%N/AN/A
Add Company

What Is Pee and Period Proof Underwear and Nursing Pads?

keywords:N/A

N/A

Total Funding

20

Number of Employees

$3.2M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pee and Period Proof Underwear and Nursing Pads News

2022-04-17 - Need to pee' pill for overactive bladder could be sold over the counter

One in six women in the UK suffer with symptoms related to an overactive bladder.

2022-04-17 - Pill to control ‘sudden urge to pee’ could be sold over the counter in UK

Millions of women suffering from an overactive bladder have been urged to take part in a consultation that could make a treatment available...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.3M20-13%N/A
#2
$2M20-5%N/A
#3
$2M20N/AN/A
#4
$2M20N/AN/A
#5
$2M20N/AN/A